Literature DB >> 28462118

Insulin resistance: vascular function and exercise.

Moon-Hyon Hwang1,2, Sewon Lee2,3.   

Abstract

Insulin resistance associated with metabolic syndrome and Type 2 diabetes mellitus is an epidemic metabolic disorder, which increases the risk of cardiovascular complications. Impaired vascular endothelial function is an early marker for atherosclerosis, which causes cardiovascular complications. Both experimental and clinical studies indicate that endothelial dysfunction in vasculatures occurs with insulin resistance. The associated physiological mechanisms are not fully appreciated yet, however, it seems that augmented oxidative stress, a physiological imbalance between oxidants and antioxidants, in vascular cells is a possible mechanism involved in various vascular beds with insulin resistance and hyperglycemia. Regardless of the inclusion of resistance exercise, aerobic exercise seems to be beneficial for vascular endothelial function in both large conduit and small resistance vessels in both clinical and experimental studies with insulin resistance. In clinical cases, aerobic exercise over 8 weeks with higher intensity seems more beneficial than the cases with shorter duration and lower intensity. However, more studies are needed in the future to elucidate the physiological mechanisms by which vascular endothelial function is impaired in insulin resistance and improved with aerobic exercise.

Entities:  

Keywords:  aerobic exercise; atherosclerosis; diabetes mellitus; metabolic syndrome; resistance exercise

Year:  2016        PMID: 28462118      PMCID: PMC5390417          DOI: 10.1016/j.imr.2016.06.001

Source DB:  PubMed          Journal:  Integr Med Res        ISSN: 2213-4220


Introduction

Insulin resistance is a metabolic disorder that reflects low capability to wash glucose out of the bloodstream to target tissues. Unlike type 1 diabetes mellitus, which results from disrupted insulin secretion from pancreatic β cells, type 2 diabetes mellitus is a representative metabolic disease attributable to increased insulin resistance and decreased insulin sensitivity. Type 2 diabetes mellitus comprises > 90% of all cases of diabetes and affected > 350 million people in 2011. In particular, the population of diabetes mellitus is gradually increasing in Korea, and about 15,000 diabetic patients die every year owing to the associated complications. Metabolic syndrome, a clinically prediabetic condition characterized by abdominal obesity, hypertension, hyperglycemia, and dyslipidemia, is closely associated with increased insulin resistance in etiology. Approximately 25% of the adult population is considered to be at risk of metabolic syndrome globally, and about 35% of the adult population in the United States is reported to have metabolic syndrome. In Korea, the population with metabolic syndrome increased from 25% in 1998 to 31% in 2007. Metabolic syndrome and type 2 diabetes mellitus are etiologically similar because they share two common causes: insulin resistance and abdominal obesity. Thus, patients with metabolic syndrome have about five times higher possibility to progress into type 2 diabetes mellitus compared with those without metabolic syndrome. Patients with type 2 diabetes mellitus or metabolic syndrome are usually at elevated risk of cardiovascular disease.2, 8, 9 Degenerative alterations in vascular structure and function in the metabolic diseases result in atherosclerosis, a main cause of cardiovascular disease. Atherosclerosis results from dysfunction of the vascular endothelium, which is closely related to decreased NO bioavailability and increased endothelium-derived contraction factors in blood vessels. Previous studies have indicated that excessive oxidative stress in the vasculature of patients with with metabolic disease is a possible mechanism to cause reduction in NO bioavailability and to impair vascular endothelial function.9, 11, 12, 13 However, few studies have demonstrated the physiological mechanisms from vascular cells in patients with metabolic disease. Regular physical activity is known as a strategy to reverse vascular dysfunction and to prevent future cardiovascular disease. However, a few studies have investigated the effect of exercise training on vascular function in patients with type 2 diabetes mellitus and metabolic syndrome.14, 15, 16, 17 Thus, the purpose of this review is to introduce potential physiological mechanisms by which vascular function is impaired in augmented insulin resistance, to summarize previous studies to investigate the effects of exercise training on vascular function in type 2 diabetes mellitus and metabolic syndrome, and to facilitate related studies in the future.

Insulin resistance and oxidative stress: a putative physiological mechanism to cause vascular dysfunction

Increased insulin resistance leads to augmented glucose level in the bloodstream. Since vascular endothelium is the single innermost layer in the vascular structure, vascular endothelial cells are likely to be damaged by hyperglycemic stress, suggesting that metabolic dysfunction such as insulin resistance and type 2 diabetic mellitus may result in vascular dysfunction. It has been demonstrated that the generation of reactive oxygen species (ROS) is increased in both large and small vascular beds collected from hyperglycemic animal models. In a hyperglycemic environment, elevated ROS generation in vascular cells can be influenced by various biological signaling pathways. Aldose reductase, in hyperglycemic conditions, converts glucose to sorbitol by using nicotinamide adenine dinucleotide phosphate as a cofactor, thus the regeneration of reduced glutathione is reduced and intracellular oxidative stress level is increased.2, 20, 21 Increased advanced glycation end-products lead to increased receptor activity, which facilitates ROS and inflammatory cytokine production.2, 22, 23 Activation of the diacylglycerol–protein kinase C pathway also contributes to the elevated generation of ROS and inflammatory cytokines.2, 24, 25, 26 In the overloaded glycolytic pathway induced by hyperglycemia, uridine diphosphate N-acetyl glucosamine has a negative effect on endothelial NO synthase activity by obstructing its phosphorylation at serine 1177 and increases the expression of proinflammatory cytokines such as transforming growth factor-β1 and plasminogen activator inhibitor-1.2, 27, 28, 29 In the vascular endothelium, oxidative stress induced by increased ROS generation not only directly plays a pivotal role in reducing NO bioavailability, but also leads to increased expression of proinflammatory cytokines so that proatherogenic and prothrombotic processes are abnormally facilitated. Thus, the structural and functional integrity of vascular endothelium is likely to be damaged with insulin resistance, which increases the risk of cardiovascular disease in those who are continuously exposed to hyperglycemia in the circulation.

Insulin resistance and exercise: effects on vascular function

Insulin signaling in local vascular cells is essential to promote vascular endothelial NO production. Thus, the increase in insulin resistance in the vasculature has a negative effect on vascular endothelial function and cardiovascular morbidity and mortality. Regular physical activity and exercise are known to promote cardiovascular health in those with insulin resistance.

Effect of exercise training on vascular function in individuals with insulin resistance

There are no specific exercise guidelines for metabolic syndrome patients to preserve and promote their cardiovascular health. Even though their joint statements were published in both 2000 and 2010, the American College of Sport Medicine and the American Diabetes Association only provide generic exercise regimens for diabetic patients.32, 33 In the two previous position standards, the experts recommended aerobic exercise or aerobic exercise combined with resistance exercise to prevent and promote cardiovascular disease risk in patients with diabetes. However, the effect of either aerobic or combined exercise training on both micro- and macrovascular endothelial function is still in debate. Some studies presented positive results of exercise training,17, 34, 35, 36 but others did not show any positive effect of exercise on vascular health in type 2 diabetic patients.37, 38, 39 For individuals with metabolic syndrome, a small number of studies have explored the effect of exercise training on vascular endothelial function, but the training effect has presented a positive tendency,14, 15, 40, 41 and had a close relationship with increased NO bioavailability. It is established that insulin resistance contributes to impaired vascular endothelial function, and either aerobic or combined exercise training programs might help to reverse endothelial dysfunction in those who have insulin resistance.14, 15, 17, 34, 35, 36, 40, 41 Exercise intensity also seems to be a main factor influencing exercise effects in people with insulin resistance. Although both moderate-intensity continuous training and high-intensity interval training have shown improvement in vascular endothelial function, in the same caloric expenditure, high-intensity interval training presents superior effect on vascular endothelial function and glycemic control.15, 36 The physiological mechanisms by which either aerobic or combined exercise training enhances vascular endothelial function in insulin resistance are not fully elucidated. Positive changes in oxidative stress and inflammatory biomarkers after exercise training are thought to be potential mechanisms from animal and systemic biomarker studies,8, 43, 44, 45 but no study has investigated the local alterations of potential biomarkers in human vasculature in response to acute or chronic exercise training in insulin resistance. Furthermore, it is also necessary to figure out a mechanistic linkage between exercise intensity and functional alteration of vascular endothelium. Table 1 shows a summary of studies examining the effect of exercise on endothelial function in individuals with insulin resistance.
Table 1

Effect of exercise training on vascular endothelial function in individuals with IR

Disease(n)Age (y)SexExmodeEx intensityEx frequencyEx time/durationVessel studiedConclusionRefs
IR (9)T2DM (14)3743BothAerobicModerate3–4 d/wk20–40 min/8 wkConduitACh-induced vasorelaxation↑34
T2DM (16)Aerobic andresistanceModerate3 d/wk1 h/8 wkConduitresistanceFlow-mediated vasodilation↑ACh-induced vasorelaxation↑35
T2DM (38)62BothAerobicandresistanceModerate3–5 d/wk75 min/12 wkConduitFlow-mediated vasodilation↑17
T2DM (43)62BothAerobicModerate3 d/wk30–40 min/3 moConduitFlow-mediated vasodilation↑36
T2DM (42)67BothAerobicandresistanceModerate3–5 d/wk20–30 min/4 wkConduitFlow-mediated vasodilation =37
T2DM (59)63BothAerobicModerate3 d/wk30 min/6 moMicro (skin)ACh-induced vasorelaxation =38
T2DM (18)60MaleAerobic andresistanceModerate3 d/wk1 h/8 wkConduitFlow-mediated vasodilation =39
MS (29)40–60MaleAerobicModerate3 d/wk50 min/12 wkConduitFlow-mediated vasodilation↑40
MS (28)BothAerobicModerateHigh3 d/wk40–47min/16 wkConduitFlow-mediated vasodilation↑Flow-mediated vasodilation↑↑14
MS (32)50–55BothAerobicModerateHigh3 d/wk40–47 min/16 wkConduitFlow-mediated vasodilation↑Flow-mediated vasodilation↑15
MS (38)50–70BothAerobicandresistanceNot addressed4–5 d/wk90 min/6 moMicro (skin)ACh-induced vasorelaxation↑41

ACh, acetylcholine; Ex, exercise; IR, insulin resistance; MS, metabolic syndrome; T2DM, Type 2 diabetes mellitus; ↑, increase; ↑↑, more increase; =, no change.

Effect of exercise on vascular dysfunction in experimental animal models

Current evidence indicates that metabolic disease such as insulin resistance or metabolic syndrome induced vascular dysfunction in various animal models (Table 2). Even though a majority of previous studies have indicated that insulin resistance or metabolic syndrome induced vascular dysfunction, some studies also showed that these prediabetic conditions did not change endothelial function. These discrepant conclusions suggest that alteration of vascular function is affected by multiple factors including duration of certain diseases and vascular beds. For example, a number of studies showed that obesity (high-fat diet) induced insulin resistance caused acetylcholine-induced endothelial dysfunction in various blood vessels, including coronary arterioles, gracilis artery, femoral artery and aorta in mouse models,46, 47, 48, 49 whereas some studies indicated that insulin resistance did not induce vascular dysfunction in femoral artery, mesentery arterioles and aorta.48, 50, 51 In addition, some studies showed that type of agonists induced inconsistent results in the same vascular beds.50, 52, 53 For instance, insulin resistance caused impaired insulin-dependent vasorelaxation, however, acetylcholine-induced vasorelaxation was identical in mesenteric arterioles of C57Bl/6J mice.50, 52 By contrast, in the femoral artery of C57BL/6J mice, insulin resistance did not change insulin-induced vasorelaxation, but acetylcholine-induced vasorelaxation was reduced by insulin resistance. Table 2 summarizes the effect of insulin resistance or metabolic syndrome on vasorelaxation in various vasculatures in experimental animal models.
Table 2

Effect of insulin resistance or metabolic syndrome on vasorelaxation in various vasculatures in experimental animal models

AnimalsSexDiseaseVessel studiedConclusionRefs
C57BL/6 miceFemaleIRCoronary arterioleACh–induced vasorelaxation ↓Flow-mediated vasorelaxation ↓46
C57BL/6J miceFemaleIRAortaACh-induced vasorelaxation ↓Insulin-induced vasorelaxation ↓48
Femoral arteryACh-induced vasorelaxation =
C57BL/6J miceMaleIRAortaACh–induced vasorelaxation =51
C57BL/6J miceMaleIRAortaACh-induced vasorelaxation ↓54
C57BL/6J miceMaleIRFemoral arteryACh-induced vasorelaxation ↓Insulin-induced vasorelaxation =53
C57BL/6J miceMaleIRCoronary arteryACh-induced vasorelaxation =Insulin-induced vasorelaxation =49
AortaACh-induced vasorelaxation ↓
C57BL/6J miceMaleIRAortaACh-induced vasorelaxation =55
C57BL/6J miceMaleMSSuperior mesentericarteryACh-induced vasorelaxation ↓56
C57BL/6J miceMaleIRMesentery arterioleACh-induced vasorelaxation =Insulin-induced vasorelaxation ↓50
C57BL/6J miceMaleIRGracilis arteryACh-induced vasorelaxation ↓47
C57BL/6J miceNot specifiedObesityFemoral arteryACh-induced vasorelaxation ↓57
C57BL/6J miceNot specifiedIRMesentery arterioleInsulin-induced vasorelaxation ↓ACh–induced vasorelaxation =52
B6D2F1 miceMaleIR by agingArtery from epididymal whiteadipose tissueACh-induced vasorelaxation ↓58
New Zealand Obese MiceMaleMSMesenteric arteryACh-induced vasorelaxation ↓Bradykinin-induced vasorelaxation ↓59
Ossabaw swineMaleMSLADCoronary blood flow ↓60

ACh, acetylcholine; IR, insulin resistance; LAD, left anterior descending; MS, metabolic syndrome; ↓, decrease; =, no change.

It is well documented that exercise or regular physical activity has beneficial effects on metabolic diseases in animal models. Considering previous studies, most exercise protocols improved vascular function in various vascular beds such as coronary arterioles, arterioles, feed arteries from skeletal muscle and aorta (Table 3). However, it is still unclear which mechanisms are involved in these beneficial effects of exercise. Table 3 summarizes the effect of exercise on vascular dysfunction induced by insulin resistance or metabolic syndrome in experimental animal models.
Table 3

Effect of exercise on vascular dysfunction induced by IR or MS in experimental animal models

AnimalsSexDiseaseVessel studiedType of EXEx effectRefs
C57BL/6 miceFemaleIRCoronary arterioleVoluntary wheel runningACh-induced vasorelaxation ↑Flow-mediated vasorelaxation ↑46
C57BL/6 miceMaleIRAortaTreadmill exerciseACh-induced vasorelaxation ↑49
OLETF ratsMaleIRArteriole fromwhite skeletal muscleVoluntary wheel runningInsulin-induced vasorelaxation ↑61
OLETF ratsMaleIRGastrocnemius feed arteryVoluntary wheel runningACh-induced vasorelaxation ↑62
Soleus feed arteryACh-induced vasorelaxation =
Low intrinsic aerobic treadmill running capacity ratsMaleMetabolic syndromeAortaContinuous moderate-intensity exercise,high-intensity aerobic interval trainingACh-induced vasorelaxation ↑63

ACh, acetylcholine; Ex, exercise; IR, insulin resistance; MS, metabolic syndrome; OLETF, Otsuka Long–Evans Tokushima Fatty; ↑, increase; =, no change.

Conclusion

There is no doubt that physical activity or regular exercise has beneficial effects on vascular function. However, it should be noted that some discrepancies exist among these studies according to experimental design including type of exercise, intensity and duration of exercise, and heterogeneity of vascular beds. It seems that vascular function in smaller resistant arteries may be altered differently compared to larger vessels such as aorta and conduit arteries, based on the status of disease, exercise type, duration, and intensity. Further investigations are needed to explain mechanisms involved in these signaling pathways.

Conflicts of interest

All authors have no conflicts of interest to declare.
  63 in total

Review 1.  Advanced glycation end products: sparking the development of diabetic vascular injury.

Authors:  Alison Goldin; Joshua A Beckman; Ann Marie Schmidt; Mark A Creager
Journal:  Circulation       Date:  2006-08-08       Impact factor: 29.690

2.  Exercise-induced improvement in vasodilatory function accompanies increased insulin sensitivity in obesity and type 2 diabetes mellitus.

Authors:  Elena De Filippis; Kenneth Cusi; Gloria Ocampo; Rachele Berria; Susan Buck; Agostino Consoli; Lawrence J Mandarino
Journal:  J Clin Endocrinol Metab       Date:  2006-10-03       Impact factor: 5.958

Review 3.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 4.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

5.  Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C.

Authors:  G M Pieper
Journal:  J Cardiovasc Pharmacol       Date:  1997-10       Impact factor: 3.105

6.  Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.

Authors:  Vincent G DeMarco; Javad Habibi; Guanghong Jia; Annayya R Aroor; Francisco I Ramirez-Perez; Luis A Martinez-Lemus; Shawn B Bender; Mona Garro; Melvin R Hayden; Zhe Sun; Gerald A Meininger; Camila Manrique; Adam Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2015-05-26       Impact factor: 10.190

7.  Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary.

Authors:  Sheri R Colberg; Ronald J Sigal; Bo Fernhall; Judith G Regensteiner; Bryan J Blissmer; Richard R Rubin; Lisa Chasan-Taber; Ann L Albright; Barry Braun
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

8.  Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome.

Authors:  Chiara Marchesi; Talin Ebrahimian; Orlando Angulo; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

9.  Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007.

Authors:  Soo Lim; Hayley Shin; Jung Han Song; Soo Heon Kwak; Seon Mee Kang; Ji Won Yoon; Sung Hee Choi; Sung Il Cho; Kyong Soo Park; Hong Kyu Lee; Hak Chul Jang; Kwang Kon Koh
Journal:  Diabetes Care       Date:  2011-04-19       Impact factor: 19.112

Review 10.  Type 2 Diabetes: Endothelial dysfunction and Exercise.

Authors:  Moon-Hyon Hwang; Sangho Kim
Journal:  J Exerc Nutrition Biochem       Date:  2014-09-26
View more
  7 in total

1.  Variability of electrochemical skin conductance for screening diabetes mellitus.

Authors:  Soochan Kim; Junghee Cho; Boncho Ku; Minho Jun; Gahye Kim; Horyong Yoo; Sangsoo Park; Jaeuk U Kim
Journal:  Biomed Eng Lett       Date:  2019-04-24

2.  Effects of interval training on cardio metabolic risk factors and nitric oxide in type 2 diabetes patients: a randomized controlled trial.

Authors:  Tahereh Arefirad; Nader Shakeri; Khosro Ebrahim; Ensieh Nasli-Esfahani
Journal:  J Diabetes Metab Disord       Date:  2020-10-01

3.  Association of abdominal aortic aneurysm diameter with insulin resistance index.

Authors:  Fabien Lareyre; Claudine Moratal; Elamine Zereg; Joseph Carboni; Patricia Panaïa-Ferrari; Pascale Bayer; Elixène Jean-Baptiste; Réda Hassen-Khodja; Giulia Chinetti; Juliette Raffort
Journal:  Biochem Med (Zagreb)       Date:  2018-10-15       Impact factor: 2.313

4.  Acute and Cumulative Effects With Whole-Body Vibration Exercises Using 2 Biomechanical Conditions on the Flexibility and Rating of Perceived Exertion in Individuals With Metabolic Syndrome: A Randomized Clinical Trial Pilot Study.

Authors:  P C Paiva; C A Figueiredo; A Reis-Silva; A Francisca-Santos; L L Paineiras-Domingos; E Martins-Anjos; M E S Melo-Oliveira; G M G Lourenço-Revelles; E Moreira-Marconi; E O Guedes-Aguiar; A A Brandão; M F T Neves; V L Xavier; D L Borges; A C R Lacerda; V A Mendonça; A Sonza; H Quinart; F C Boyer; R Taiar; A Sartorio; D J Cochrane; M Bernardo-Filho; D C Sá-Caputo
Journal:  Dose Response       Date:  2019-11-22       Impact factor: 2.658

5.  Type 2 diabetes progression differently affects endothelial function and vascular contractility in the aorta and the pulmonary artery.

Authors:  Bernardete F Melo; Jesus Prieto-Lloret; Marlene D Cabral; Fatima O Martins; Inês B Martins; Joana F Sacramento; Pedro Ruivo; Tânia Carvalho; Silvia V Conde
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

Review 6.  Capsaicin in Metabolic Syndrome.

Authors:  Sunil K Panchal; Edward Bliss; Lindsay Brown
Journal:  Nutrients       Date:  2018-05-17       Impact factor: 5.717

Review 7.  Obesity and Erectile Dysfunction: From Bench to Clinical Implication.

Authors:  Ki Hak Moon; So Young Park; Yong Woon Kim
Journal:  World J Mens Health       Date:  2018-07-25       Impact factor: 5.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.